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Introduction
The existence of counterfeit designer clothes, handbags and watches 
is well known and there is a growing public awareness of the existence 
of counterfeit medicines arising from the ‘lifestyle’ drugs Viagra and 
Cialis. Counterfeiters are now also focusing on prescription medicines 
including ‘lifesaving’ medicines for cancer and heart disease [1-3]. 
For patients the use of counterfeit medicines can result in unexpected 
side effects, treatment failure or even death. Counterfeit medicines are 
in fact a vast global problem impacting not only on the developing 
countries but also on the developed countries with effective regulatory 
systems and market control. In the last decade conservative estimates 
suggest that, taken globally, 10% of all medicines are counterfeit [3,4]. 
The World Health Organisation defines a counterfeit medicine as ‘a 
medicine which is deliberately and fraudulently mislabelled with 
respect to its identity and/or source’ and may include but not limited to: 
medicines containing no active ingredient, the wrong amount of active 
ingredient, the wrong active ingredient, high levels of contaminants 
and fake packaging. These statements apply to both branded and 
generic products and to traditional medicines [5]. 
Controlling the quality of medicines available to the public is 
challenging in both developed countries and those countries with 
limited resources. Access to the internet increases the opportunities 
for possible exposure to counterfeits such as Viagra where counterfeit 
levels have been estimated to be as high as 70% of the products available 
[6]. Less well-resourced countries struggle to provide the necessary 
quality control and quality assurance (QC/QA) procedures to protect 
the public from exposure to counterfeit medicines. In these countries, 
where poor quality medicines continue to be a burden, there is neither 
the analytical capability to identify a problem nor a sufficiently strong 
regulatory framework to take corrective action when counterfeit 
medicines are identified [7]. 
The following examples of identified counterfeit medicines 
reinforce the global nature of the problem:
•	 Belgium: fake traditional Chinese medicines resulting in several 
deaths and excess cancer cases [8] and major skin problems 
associated with counterfeit skin whitening creams [9].
•	 Sub-Sahara Africa: Up to 40% of anti-malarial medication and 
anti-HIV medication thought to be counterfeit [10] resulting 
in an unknown number of deaths and the potential for disease 
resistance to develop.
•	 Pakistan: in 2011/12 counterfeit cardiovascular medication 
resulted in some 400+ deaths [11].
•	 India: both high and low levels of the active ingredient in 
simple over the counter medicines have been identified [12].
•	 China: problems have been identified with both anti-cancer 
and diabetes drugs [13].
•	 USA: the lifestyle medications provide the major examples 
[2,3] and counterfeit anti-cancer drugs are also a concern [14] 
possibly due to the high cost of the genuine products.
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•	 South America: Steroids and contraceptives are the target 
materials in these countries [15].
•	 UK: in the National Health Service (NHS) possibly the most 
rigorously controlled medicines supply system it is estimated 
that around 1% of all medicines are counterfeit. Furthermore it 
is estimated that circa 50% of medicines from the internet are 
counterfeit [16,17].
In terms of the types of counterfeit medicines the products reported 
by WHO were grouped into the following categories [18]:
•	 No	active	ingredient	32%
•	 Wrong	active	ingredient			 	 22%
•	 Wrong	content	 	 	 20%
•	 Counterfeit	packaging	 	 16%
•	 Contaminated	 	 	 	9%
•	 Copies	of	original	product	 	 1%
This pervasive spread of counterfeit medicines demands that efforts 
be made to find rapid detection methods to control the penetration 
of the market in order to protect the patient, to protect profits for 
the pharmaceutical industries and very importantly to prevent drug 
resistance developing as a result of incomplete dosing regimes [19,20]. 
As the counterfeiters become more skilled well-resourced countries 
can apply more sophisticated analytical techniques such as LC-MS/
MS and NMR to detect these more subtle changes [21]. With increased 
scan speeds and lower levels of detection these techniques are capable 
of identifying more compounds present in a larger number of samples 
leading to what is known in the UK as BIG DATA. Whilst this approach 
is becoming mandatory for metabolomic studies, in drug development 
work for example, it cannot be used by a poorly resourced country to 
deliver on a vital part of its healthcare requirements i.e. is this a good 
quality medicine or not? Such countries need simplified screening 
methods which are rugged, portable and do not need sophisticated 
laboratories or costly reagents [22]. Screening will reduce the number 
of samples that must be processed by a central QC laboratory which 
will in turn reduce costs and reduce the time delays for the patient’s 
treatment. There have been several approaches to develop suitable 
screening systems including the Minilab™ based on TLC test methods 
[16], a handheld Raman Spectroscopy device [5] and systems based on 
Near Infrared Spectroscopy (NIR) [17]. The Minilab™ requires training 
in handling chemicals and the test sample has to be solvent extracted 
prior to analysis which increases both the time and complexity of each 
test. Spectroscopic tests require little or no sample preparation and 
the ease of operation of the equipment and rapid generation of results 
make them potentially ideal for screening purposes.
Attenuated Total Reflection Infra-Red (ATR FT/IR) analysis (Figure 
1) offers a similar capability in terms of simple sample treatment. Paste 
or powder samples can be applied directly to the sensing head and 
tablet samples need only to be crushed prior to analysis. Once analysed 
the sample is available to the patient, albeit in powder form and in this 
respect the technique can be classed as non-destructive.  Applications 
of ATR techniques to identify possible fakes based on principal 
component analysis have been reported [9] but this is the first report of 
quantitative estimation of the active pharmaceutical ingredient (API) 
level in a series of formulations. This paper reports on the evaluation of 
an ATR FT/IR instrument for the qualitative and quantitative analysis 
of commercial pharmaceutical tablet products. The ability of the 
system to identify the active pharmaceutical ingredient, paracetamol, 
in the presence of the excipients was determined. Finally the potential 
of the system to measure the actual level of this active pharmaceutical 
ingredient again in the presence of the excipients was assessed.
Materials and Methods
Reference chemicals: Paracetamol (Acetaminophen) was used 
for this investigation as representative of a common OTC medicine. 
Furthermore Paracetamol is often combined with other active 
ingredients, in the same tablet, providing an opportunity to assess the 
presence of this material with other active ingredient/s present.
A reference samples of Paracetamol (Acetaminophen) was 
obtained from Sigma-Aldrich Company, Dorset UK. The materials 
used to produce simulated excipient formulations: magnesium stearate, 
calcium carbonate, titanium dioxide and carboxymethyl cellulose were 
obtained from Fisher Scientific Ltd. Loughborough, UK.
Test tablet samples: The paracetamol tablets collected for analysis 
from the UK, Belgium, India, China and Rwanda were coded as follows:
•	 Europe	 	 EU	UK	1	/	EU	UK	2	/EU		B1	/EU	B2
•	 Africa	 	 OYEM	27	/	OYEM	28	/	OYEM	42(2)	/								
	 	 	 OYEM	49	(2)
•	 China	 	 China	2#1	/	China	1	/	HK	1	/	HK	2
•	 India	 	 India	1#2	/	India	1#3	/	India	2#1	/	India																				
	 	 	 3#1	/	India	4#2	/	India	5#2	/	India	6#1
A total of 47 tablets were analysed. The expected amount of 
Paracetamol in each of the tablets was 500 mg as indicated on the packet 
except for Paracetamol Belgium and a Paracetamol India sample which 
were expected to contain 1000 mg and 325 mg respectively.
Instrumental
ATR FT/IR: ATR FT/IR data was generated using the FTIR 2 Bruker 
Alpha spectrometer with its accompanying platinum diamond ATR 
sampling accessory. The background spectrum within the instrument 
was recorded prior to the start of the analysis and subsequently after 
every fifth sample. This spectrum, notably from water vapour, was 
subtracted from the acquired sample spectra. The system scanned 
each sample 20 times over the range 4000-400 cm-1 measured at a 
spectral resolution of 2 cm-1. Spectral data were processed using OPUS 
software 7.2 (Bruker Corporation) and recorded as absorbance data. 
In quantitative mode measurements were made using the different 
integration modes provided by the software:-
•	 Mode	A	–	integrates	the	area	between	the	band,	abscissa	and	
the frequency limits defined.
•	 Mode	 B	 –	 integrates	 the	 area	 above	 a	 straight	 line	 drawn	
between the peaks of the two frequency limits defined.
•	 Mode	J-measures		the	highest	absolute	peak	intensity
Figure 1: ATR FT/IR principle.
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•	 Mode	 K-measures	 the	 peak	 intensity	 relative	 to	 the	 local	
baseline. 
UV – Vis Instrument: UV spectra were collected using UV-Visible 
spectrophotometer,	 Helios	 Gamma	 (Thermo	 Electron	 Corporation	
England).	 The	 studied	 spectral	 range	 was	 190-400	 nm	 with	 a	 scan	
interval of 0.5 nm. The UV-Visible spectrophotometer was controlled 
using the Vision Lite software 2.2 (Ueberlingen, Germany).
Methods
Individual finely ground samples of the reference materials and 
the crushed tablets were placed on the diamond sampling head and 
5 separate spectra recorded for each sample. This was repeated for 3 
different powder portions from each sample. Comparison of these 
results was used to identify characteristic fingerprint data for the target 
active ingredient and also to assess the reproducibility of the data. Opus 
7.2 integration methods were used in conjunction with the fingerprint 
peaks to assess the potential to quantify the level of Paracetamol 
present. Measured levels of API correspond to the percentage level 
present in the final tablet formulation and were related to the actual 
dosage through the mass of the tablet. Calibration powder mixtures of 
Paracetamol in magnesium stearate were prepared at 20, 30, 40, 60, 70, 
80 and 90% of Paracetamol in the tablet, covering the different dose 
levels in common UK OTC medicines. The spectra of these mixtures 
were recorded as detailed above. Calibration graphs were prepared for 
individual fingerprint peaks using each of the integration routines. The 
data obtained for each fingerprint peak, using a particular integration 
mode was then combined to give a mean result. This quantification 
approach was used to determine the level of the stated API in crushed 
Paracetamol tablets obtained from eclectic sources around the world. 
As a final check on the validity of the data obtained the level of 
Paracetamol in each tablet was determined by conventional solvent 
extraction analysis in a method analogous to that cited by the British 
Pharmacopoeia. The protocol used by Behera [23] was adopted for this 
part of the study.
Results and Discussion
Spectral reproducibility
Replicate samples of the reference materials were run and 
providing the instrumental conditions remained constant there were 
no detectable differences in peak positions in the fingerprint region 
(1900-400 cm-1) between individual samples of the same material. 
Some variations in signal intensity, between replicate samples were 
initially noted but the cause was traced to either incomplete coverage of 
the sampling area or to poor sample homogenisation. Once a standard 
procedure was adopted reproducible spectral data was obtained across 
the complete scan range (4000-400 cm-1).
Fingerprint data
Characteristic fingerprint spectra for the selected excipients and 
Paracetamol, recorded from the pure reference compounds, indicated 
both the characteristic peaks for a particular compound and the regions 
of spectral overlap.
Figure 2 shows the relatively simple spectrum obtained from 
magnesium stearate and clearly indicates the presence of potentially 
interfering peaks between 1700 and 1400 cm-1 which should be avoided.
The data shown in Figure 3 demonstrates the close agreement 
between the reference spectra for pure Paracetamol (upper) and the 
data obtained the analysis of the powder from a crushed Paracetamol 
tablet (lower trace). This close agreement between the spectra confirms 
the presence of Paracetamol in the tablet formulation. The peaks at 
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Figure 2: Multiple spectra overlay for magnesium stearate system demonstrating reproducibility.
Citation: Lawson G, Ogwu J, Tanna S (2014) Counterfeit Tablet Investigations: Can ATR FT/IR Provide Rapid Targeted Quantitative Analyses? J 
Anal Bioanal Tech 5: 214 doi:10.4172/2155-9872.1000214
Page 4 of 6
Volume 5 • Issue 5 • 1000214
J Anal Bioanal Tech
ISSN: 2155-9872 JABT, an open access journal 
1770 and 1716 cm-1 were only seen in this sample and were presumed 
to be from the excipient mix in the tablet formulation.
In order to avoid major interference from the excipient peaks the 
characteristic peaks selected for paracetamol for this investigation 
were: 1225 cm-1, 1172 cm-1, 1108 cm-1, 603 cm-1.
Quantification
Individual calibration graphs, using each of the integration modes, 
were plotted for the characteristic peaks selected. Data was recorded 
from 5 replicate samples for each concentration. For brevity only one 
example of these graphs is reproduced here (Figure 4) and the other 
data is given as the calibration equation of best fit and the associated r2 
value to give an indication of the quality of the data.
Mode A
	 y=0.14x	–	0.708		 (1225cm-1) r2=0.9922
 y=0.0301x+0.3367 (1172cm-1) r2=0.9952
 y=0.02x+0.662 (1108cm-1) r2=0.9879
 Mode B
	 y=0.0387x	–	0.5437		(1225cm-1) r2=0.9743 
 y=0.0071x-0.0486 (1172cm-1) r2=0.9855
 y=0.0067x+0.0316 (1108cm-1) r2=0.9877
 y=0.0277x-0.3385 (603cm-1) r2=0.9927
	 Mode	J
	 y=0.0043x	–	0.0211		(1225cm-1) r2=0.9837
 y=0.002x+0.0056  (1172cm-1) r2=0.9905
 y=0.0014x+0.0307 (1108cm-1) r2=0.9864
 Mode K
	 y=0.0018x	–	0.0323		(1225cm-1) r2=0.9734
 y=0.0011x-0.0094 (1172cm-1) r2=0.9807
 y=0.0009x+0.0005 (1108cm-1) r2=0.9862
 y=0.0018x+0.0157 (603cm-1) r2=0.9969
During this phase of the investigation the critical dependence 
on good mixing was noted as indicated by r2 values improving with 
increased mixing time.
Qualitative results confirm that all the tablets tested contained 
paracetamol. Quantitative assessment using the ATR approach gave 
values	 around	 that	 expected	 for	 all	 the	 samples	 except	 for	 India	4#2	
(Table 1).Not only was the level of API too high but there was also 
a large SD. The trace for this sample is shown in Figure 3 and as can 
be seen the top of the peak at 1108 cm-1 is in the same position for 
both this sample and pure paracetamol. This was not the case for the 
other peaks selected for this work. Measurements using modes A and 
J	would	therefore	produce	an	incorrect	high	API	level	for	this	sample.	
The combination of correct (1225, 1172 and 603 cm-1) and artificially 
high data will result in the high standard deviation data observed. 
This observation suggests that the discriminatory nature of the peak 
at 1108 cm-1 is less good in this particular sample possibly due to the 
presence of a second API in the tablet which contributes to the signal 
at this wavelength.  There may also be a contribution from the baseline 
correction prior to data collection particularly for lower levels of 
Figure 3: Overlay of pure paracetamol (Upper) and a paracetamol tablet sample. Tharfenac (Lower).
Citation: Lawson G, Ogwu J, Tanna S (2014) Counterfeit Tablet Investigations: Can ATR FT/IR Provide Rapid Targeted Quantitative Analyses? J 
Anal Bioanal Tech 5: 214 doi:10.4172/2155-9872.1000214
Page 5 of 6
Volume 5 • Issue 5 • 1000214
J Anal Bioanal Tech
ISSN: 2155-9872 JABT, an open access journal 
paracetamol. The limit of quantification was shown to be around 15% 
based on the tablet mass and for a real tablet this would be around 
60 mg based on a 400 mg tablet. The very low SDs for the first three 
Indian samples is probably indicative of no contribution to any of the 
marker peaks due to a fortuitous choice of the excipients in the tablets. 
Given that no sample clean-up is used the other SD levels observed are 
considered to be acceptable.  
It was interesting to note that the UV measurements tended towards 
higher than expected API levels. There was general agreement within 
the data from the ATR FT/IR measurements with a trend towards 
lower estimated values of the API level than from the UV method.
Conclusions 
The main objective of this study was to find a simple, economic, 
rapid and robust analytical method being suitable for the qualitative and 
quantitative analysis of APIs in tablet dosage forms. The simple ATR 
FT/IR approach employed in this study provides a rapid identification 
of the API in the presence of excipients. Identification of Paracetamol 
in the presence of excipients was possible at >10% w/w in the tablet 
and is viable within 5 minutes. Quantification of the Paracetamol can 
be obtained from the same sample within the same time frame. The 
results confirmed that the ATR FT/IR method was able to both identify 
and quantify the presence of the target API without the use of solvents 
and in timescales appropriate to development as a screening technique. 
Conventional FTIR samples would produce similar results but extra 
equipment, for example a KBr disc press would be required along with 
skilled staff to produce useable quality discs. Mulls would also require 
extra chemicals and equipment and both these approaches would 
detract from the simplicity and robustness of the ATR based system. 
Figure 4: Calibration graph for paracetamol in magnesium stearate measures at 1225 cm-1 using Mode A.
Tablet UV Measured Content (mg)
Mode A MEAN ± SD 
(mg) Mode B MEAN ± SD (mg) Mode J MEAN ± SD (mg)




EU UK 1 532 ± 4 419 ± 18 429 ± 28 450 ± 26 461 ± 53 500
EU UK 2 479 ± 3 417 ± 22 442 ± 32 456 ± 31 476 ± 58 500
EU B 1#1 1031 ± 8 974 ± 11 977 ± 78 1036 ± 37 1050 ± 127 1000
EU B 2#1 1090 ± 8 981 ± 12 986 ± 79 1049 ± 44 1065 ± 134 1000
OYEM 27 543 ± 4 426 ± 10 422 ± 33 447 ± 21 446 ± 56 500
OYEM 28 476 ± 3 436 ± 13 440 ± 32 466 ± 25 475 ± 60 500
OYEM 42 (2) 581 ± 4 537 ± 53 448 ± 38 524 ± 21 472 ± 63 500
OYEM 49 (2) 519 ± 4 445 ± 15 422 ± 37 456 ± 23 440 ± 57 500
China 2#1 495 ± 3 432 ± 12 419 ± 39 455 ± 21 456 ± 66 500
China 1 541 ± 4 412 ± 10 410 ± 36 441 ± 23 450 ± 62 500
HK 1 488 ± 3 475 ± 24 431 ± 24 492 ± 32 468 ± 54 500
HK 2 548 ± 4 512 ± 21 457 ± 24 529 ± 29 494 ± 56 500
India 1#2 499 ± 4 460 ± 25 407 ± 40 464 ± 7 439 ± 63 500
India 1#3 528 ± 4 447 ± 20 405 ± 40 455 ± 8 435 ± 62 500
India 2#1 478 ± 3 462 ± 35 412 ± 37 462 ± 7 435 ± 61 500
India 3#1 504 ± 3 438 ± 15 434 ± 39 465 ± 30 469 ± 68 500
India 4#2 358 ± 3 487 ± 283 253 ± 77 510 ± 88 327 ± 87 325
India 5#2 545 ± 5 447 ± 22 445 ± 41 480 ± 38 487 ± 73 500
India 6#1 521 ± 5 499 ± 67 392 ± 40 472 ± 30 400 ± 58 500
Table 1: Summary of the quantitative results from the analyses of the Paracetamol tablets.
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There would also be an additional time constraint of between 10 and 
30 minutes per sample depending on the skill of the staff preparing the 
KBr disc or mull samples. UV analyses took around 60 minutes per 
sample versus only a few minutes for ATR FT/IR which also provided 
unique identification information in the form of the spectral data 
collected. This method provides a quick and simple way to identify 
counterfeit Paracetamol tablets and has the potential to be applied to 
tablet formulations containing other APIs.
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